Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00690092 · ClinicalTrials.gov registry record · Phase 3
A Multi-center Study of Spherule-Derived Coccidioidin
A Phase 3 study, sponsored by Nielsen BioSciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 113
- Enrollment target
NCT00690092 is a Phase 3 study that has completed, run by Nielsen BioSciences. The registered enrollment target is 113 participants.
The verdict
NCT00690092, a Phase 3 study, has completed, sponsored by Nielsen BioSciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 113 participants
- Enrollment target
Study Summary
Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Induration greater than or equal to 5 mm after 48 hours was considered positive for exposure to C. immitis.
Interventions
- BIOLOGICAL Spherule-derived coccidioidin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00690092
The ClinicalTrials.gov registry entry for NCT00690092 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nielsen BioSciences, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spherule-derived coccidioidin is the first listed.
NCT00690092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00690092 about?
NCT00690092 is a clinical study titled "A Multi-center Study of Spherule-Derived Coccidioidin". Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Indurat...
What is the current status of trial NCT00690092?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 113 participants. The study started on 2005-05. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00690092?
The interventions under investigation include: Spherule-derived coccidioidin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00690092?
This trial is sponsored by Nielsen BioSciences, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.